Since then, several case reports have shown dupilumab to be an effective treatment for different subtypes of pemphigoid, including adolescent BP, eczema-like BP, IgA BP, anti-PD-1/PD-L1-induced BP, vesicular pemphigoid, and pemphigoid nodularis (19–32). The gene discussed is CD79A; the disease is Eczematoid dermatitis.